ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DSM has agreed to acquire the fermentation-derived flavor and fragrance ingredients developed by the industrial biotech firm Amyris for $150 million. The firms will also share in future profits from the business and continue their R&D partnership. DSM bought Amyris’s farnesene business and the manufacturing site in Brotas, Brazil, where the intermediate is made in 2017. DSM has since been making several ingredients for Amyris at the facility.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter